The present disclosure relates to a polypeptide fragment selected from the group consisting of a fragment of Eq48, and a fragment of Eq39. Eq48 and Eq39 are two surface proteins encoded by Streptococcus equi subspecies equi. The polypeptide fragments are useful for detection of exposure of a subject to Streptococcus equi 5 subspecies equi. Thus, the present disclosure furthermore relates to methods of use of such polypeptides.
G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceuticals, medical and veterinary preparations;
vaccines; vaccine preparations; veterinary vaccines;
veterinary preparations and substances; diagnostic
preparations and materials, for medical and veterinary
purposes. Veterinary services; information services relating to
veterinary pharmaceuticals; veterinary analysis services for
diagnostic or treatment purposes; information services
relating to the veterinary pharmaceutical industry;
veterinary advisory services; providing veterinary
information.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceuticals, medical and veterinary preparations for the treatment of streptococcus suis; vaccines; Vaccine preparations for the treatment of streptococcus suis; veterinary vaccines; Veterinary preparations and substances for the treatment of streptococcus suis; Diagnostic preparations, agents, and substances for medical and veterinary purposes Veterinary services; Information services relating to veterinary pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; veterinary analysis services for diagnostic or treatment purposes; Information services relating to the veterinary pharmaceutical industry, namely, providing veterinary information; Veterinary advisory services, namely, veterinary services; providing veterinary information.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Pharmaceuticals, medical and veterinary preparations; vaccines; vaccine preparations; veterinary vaccines; veterinary preparations and substances; diagnostic preparations and materials, for medical and veterinary purposes. (1) Veterinary services; information services relating to veterinary pharmaceuticals; veterinary analysis services for diagnostic or treatment purposes; information services relating to the veterinary pharmaceutical industry; veterinary advisory services; providing veterinary information.
5.
STREPTOCOCCUS SUIS VACCINE COMPOSITION COMPRISING IMMUNOGENIC FUSION POLYPEPTIDES
The present disclosure relates to immunogenic fusion polypeptides, immunogenic compositions and vaccine compositions comprising said fusion polypeptides and use thereof for immunization of mammals susceptible to Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceuticals, medical and veterinary preparations; Vaccines; Vaccine preparations; Veterinary vaccines; Veterinary preparations and substances; Diagnostic preparations and materials, for medical and veterinary purposes.. Veterinary services; Information services relating to veterinary pharmaceuticals; Veterinary analysis services for diagnostic or treatment purposes; Information services relating to the veterinary pharmaceutical industry; Veterinary advisory services; Providing veterinary information..
7.
STREPTOCOCCUS SUIS VACCINE COMPOSITION COMPRISING IMMUNOGENIC FUSION POLYPEPTIDES
Title: STREPTOCOCCUS SUIS VACCINE COMPOSITION COMPRISING IMMUNOGENIC FUSION POLYPEPTIDES Abstract: The present disclosure relates to immunogenic fusion polypeptides, immunogenic compositions and vaccine composi¬ tions comprising said fusion polypeptides and use thereof for immunization of mammals susceptible to Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
8.
STREPTOCOCCUS SUIS VACCINE COMPOSITION COMPRISING IMMUNOGENIC FUSION POLYPEPTIDES
Streptococcus suisStreptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
The present disclosure relates to immunogenic polypeptides, immunogenic compositions and vaccine compositions and use thereof for immunization of mammals susceptible to Streptococcus suis infection. The disclosure also relates to methods for preparing, formulating and administrating such compositions.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
A61K 39/00 - Medicinal preparations containing antigens or antibodies
13.
Vaccine against streptococcal infections based on recombinant proteins
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
A61K 39/00 - Medicinal preparations containing antigens or antibodies
15.
Vaccine against streptococcal infections based on recombinant proteins
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
A61K 39/00 - Medicinal preparations containing antigens or antibodies
16.
VACCINE AGAINST STREPTOCOCCAL INFECTIONS BASED ON RECOMBINANT PROTEINS
An antigenic composition comprises several antigenic components derived from antigens of Streptococcus equi subsp. equi or subsp. zooepidemicus, wherein at least one component is a fusion protein or polypeptide comprising two or more such antigens or fragments thereof. The antigenic composition may be used for immunization of mammals against S. equi subsp. equi and/or subsp. zooepidemicus. A vaccine composition comprising the antigenic composition as immunizing component is also disclosed.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
An antigenic composition comprises at least one antigen, wherein said at least one antigen comprises at least part of a protein selected from EndoSe of Streptococcus equi subsp. Equi, EndoSz of Streptococcus equi subsp. zooepidemicus, and Endo S of Streptococcus pyogenes, and wherein said at least part of said protein comprises at least one antigenic epitope. A vaccine composition comprising the antigenic composition as immunizing component, methods for producing the antigeninc composition and the vaccine composition, use of the vaccine composition for prophylactic and therapeutic treatment, and an antibody preparation comprising monoclonal or polyclonal antibodies specific for an antigen or antigens of the antigenic composition are also discosed.
The present invention is concerned with an antigenic composition comprising at least one antigen that comprises at least one antigenic epitope or antigenic determinant derived from a protein present in one or both of S. equi subsp. equi and subsp. zooepidemicus and use thereof for immunization of non-human mammals against S. equisubsp. equi and/or subsp. zooepidemicus.The present invention also discloses a vaccine composition comprising the aforesaid antigenic composition as immunizing component.
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
A61K 39/40 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum bacterial
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
Zooepidemicus. The present invention also discloses a vaccine composition comprising the aforesaid antigenic composition as immunizing component. The antigens used are EAG, FNZ, SFS, SEC and ScLC.
